University of Colorado - Aurora Cancer Center

Aurora, Colorado 80045

3 studies enrolling now · 7 studies all time

What they study most

Acquired Resistance to KRAS G12C Inhibitor, Advanced Solid Tumor, B-cell Acute Lymphoblastic Leukemia, BRAF, BRAF Gene Mutation, BRAF Mutation-Related Tumors, BRAF V600 Mutation, BRAF V600E, Brain Metastases, Colorectal Cancer, Colorectal Carcinoma, Graft-versus-host Disease (GVHD)

Studies at this site

• A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors — Recruiting now
• Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies — Recruiting now
• Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01) — Recruiting now
• GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease — Completed
• A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera — Running, not enrolling
• A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors — Stopped early
• Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis — Status unconfirmed